Skip to main content

Table 3 Effect of haplogroups on breast, colorectal and thyroid cancer occurrences

From: Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer

Haplogroup CCS of breast cancer P value CCS of colorectal cancer P value CCS of thyroid cancer P value
  Controls Cases OR   Controls Cases OR   Controls Cases OR  
  (N = 114) (N = 104) (95%CI)   (N = 125) (N = 108) (95%CI)   (N = 138) (N = 100) (95%CI)  
M 60 69 1.77(1.03-3.07) 0.040* 61 53 1.01(0.60-1.69) 0.967 70 55 1.19(0.71-1.99) 0.514
   D 26 28 1.25(0.67-2.31) 0.482 32 26 0.92(0.51-1.67) 0.788 34 33 1.51(0.85-2.66) 0.157
D4 21 15 0.75(0.36-1.54) 0.427 23 19 0.95(0.48-1.85) 0.873 26 27 1.59(0.86-2.94) 0.135
D4a 6 4 0.72(0.20-2.63) 0.617 9 6 0.76(0.26-2.20) 0.610 6 12 3.00(1.09-8.29) 0.028*
D5 5 13 3.11(1.07-9.06) 0.030* 9 7 0.89(0.32-2.49) 0.829 8 6 1.04(0.35-3.09) 0.948
   G 2 7 4.04(0.82-19.91) 0.065 3 0 - 0.105 3 1 0.46(0.05-4.44) 0.487
   M8 8 15 2.23(0.91-5.51) 0.075 8 9 1.33(0.49-3.58) 0.571 11 6 0.74(0.26-2.06) 0.560
   M7 16 8 0.51(0.21-1.25) 0.135 13 9 0.78(0.32-1.91) 0.591 15 11 1.01(0.44-2.31) 0.975
   M10a 2 5 2.83(0.54-14.90) 0.202 1 3 3.54(0.36-34.57) 0.246 3 0 - 0.138
N             
   A 10 4 0.42(0.13-1.37) 0.138 10 9 1.05(0.41-2.68) 0.926 11 9 1.14(0.46-2.87) 0.778
   N9 3 4 1.48(0.32-6.78) 0.611 5 7 1.66(0.51-5.40) 0.393 4 5 1.76(0.46-6.74) 0.402
   R 41 27 0.62(0.35-1.12) 0.111 48 36 0.80(0.47-1.37) 0.422 52 27 0.61(0.35-1.07) 0.084
B 23 14 0.69(0.33-1.44) 0.322 24 20 0.96(0.50-1.85) 0.895 26 16 0.82(0.41-1.63) 0.570
B4 16 8 0.51(0.21-1.25) 0.135 17 9 0.58(0.25-1.36) 0.203 19 9 0.62(0.27-1.43) 0.260
B5 7 5 0.77(0.24-2.51) 0.667 7 11 1.91(0.71-5.12) 0.191 7 7 1.41(0.48-4.15) 0.533
F 13 11 0.92(0.39-2.15) 0.846 19 16 0.97(0.47-2.00) 0.935 22 11 0.65(0.30-1.41) 0.276
  1. P values were estimated by "chi-square test"; (*) indicated statistical significant (P < 0.05). OR indicates odds ratio; 95% CI, 95%confidence interval.